Goldman Sachs’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-25,400
| Closed | -$5.22M | – | 6528 |
|
|
2025
Q4 | $5.22M | Sell |
25,400
-46,000
| -64% | -$8.66M | ﹤0.01% | 3699 |
|
|
2025
Q3 | $11.2M | Sell |
71,400
-36,000
| -34% | -$5.56M | ﹤0.01% | 2850 |
|
|
2025
Q2 | $18M | Buy |
107,400
+91,200
| +563% | +$13.5M | ﹤0.01% | 2215 |
|
|
2025
Q1 | $2.23M | Buy |
+16,200
| New | +$2.06M | ﹤0.01% | 4067 |
|
|
2024
Q1 | – | Sell |
-62,500
| Closed | -$6.3M | – | 5578 |
|
|
2023
Q4 | $6.3M | Buy |
+62,500
| New | +$6.2M | ﹤0.01% | 2969 |
|
|
2023
Q3 | – | Sell |
-169,200
| Closed | -$16M | – | 5569 |
|
|
2023
Q2 | $16M | Buy |
+169,200
| New | +$14.3M | ﹤0.01% | 2040 |
|
|
2021
Q2 | – | Sell |
-4,300
| Closed | -$261K | – | 6212 |
|
|
2021
Q1 | $261K | Buy |
+4,300
| New | +$237K | ﹤0.01% | 5497 |
|
|
2018
Q1 | – | Sell |
-18,000
| Closed | -$1.1M | – | 5930 |
|
|
2017
Q4 | $1.1M | Sell |
18,000
-10,500
| -37% | -$649K | ﹤0.01% | 4264 |
|
|
2017
Q3 | $1.91M | Buy |
28,500
+9,300
| +48% | +$657K | ﹤0.01% | 4040 |
|
|
2017
Q2 | $1.5M | Buy |
19,200
+2,500
| +15% | +$189K | ﹤0.01% | 4086 |
|
|
2017
Q1 | $1.36M | Sell |
16,700
-15,400
| -48% | -$1.21M | ﹤0.01% | 4104 |
|
|
2016
Q4 | $2.31M | Buy |
32,100
+18,900
| +143% | +$1.37M | ﹤0.01% | 3721 |
|
|
2016
Q3 | $1.03M | Sell |
13,200
-4,400
| -25% | -$356K | ﹤0.01% | 4375 |
|
|
2016
Q2 | $1.37M | Buy |
17,600
+400
| +2% | +$31.9K | ﹤0.01% | 3930 |
|
|
2016
Q1 | $1.41M | Sell |
17,200
-40,300
| -70% | -$3.28M | ﹤0.01% | 3786 |
|
|
2015
Q4 | $5.13M | Sell |
57,500
-19,300
| -25% | -$1.64M | ﹤0.01% | 2799 |
|
|
2015
Q3 | $5.9M | Buy |
76,800
+49,500
| +181% | +$4.14M | ﹤0.01% | 2737 |
|
|
2015
Q2 | $2.28M | Buy |
27,300
+7,800
| +40% | +$689K | ﹤0.01% | 3708 |
|
|
2015
Q1 | $1.76M | Buy |
19,500
+4,700
| +32% | +$405K | ﹤0.01% | 3916 |
|
|
2014
Q4 | $1.2M | Sell |
14,800
-9,000
| -38% | -$711K | ﹤0.01% | 4377 |
|
|
2014
Q3 | $1.78M | Sell |
23,800
-17,800
| -43% | -$1.3M | ﹤0.01% | 4053 |
|
|
2014
Q2 | $2.85M | Buy |
41,600
+1,800
| +5% | +$123K | ﹤0.01% | 3639 |
|
|
2014
Q1 | $2.79M | Sell |
39,800
-81,000
| -67% | -$5.63M | ﹤0.01% | 3648 |
|
|
2013
Q4 | $8.07M | Buy |
120,800
+36,100
| +43% | +$2.21M | ﹤0.01% | 2568 |
|
|
2013
Q3 | $4.42M | Sell |
84,700
-117,200
| -58% | -$5.95M | ﹤0.01% | 3061 |
|
|
2013
Q2 | $9.53M | Buy |
+201,900
| New | +$9.22M | ﹤0.01% | 2141 |
|
Other funds holding CAH
VCM
VPM
Goldman Sachs's CAH Position: Q1 2026 in Review
Goldman Sachs increased its Cardinal Health (CAH) stake by 16% in Q1 2026, buying an estimated $68.9M and bringing the position to 2,371,854 shares worth $501M. The position accounts for 0.06% of the portfolio, ranked #348.
Goldman Sachs first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Goldman Sachs held 2,371,854 shares of Cardinal Health worth $501M as of Q1 2026.
- Goldman Sachs bought 320,121 Cardinal Health shares in Q1 2026, an estimated $68.9M.
- Cardinal Health made up 0.06% of Goldman Sachs's portfolio in Q1 2026, its #348 holding.
- Goldman Sachs first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.